Study: NCT04223895

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 1
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 1
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 1
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 1
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 1
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 1
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 2
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 2
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 2
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 2
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 2
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386 Formulation 2
Description: A single oral dose of 1 tablet under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326 and D337
Description: A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326 and D337
Description: A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326 and D337
Description: A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326 and D337
Description: A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326 and D337
Description: A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D012, D326 and D337
Description: A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period